MA26414A1 - Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant. - Google Patents

Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.

Info

Publication number: MA26414A1
Authority: MA; Morocco
Prior art keywords: quinoleine; preparation; new; pharmaceutical formulations; formulations containing
Prior art date: 1995-12-23

Application number

MA24433A

Other languages

English (en)

Inventor

John Collis Alan

Newman Julie

Nathan Abraham David

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-23

Filing date

1996-12-18

Publication date

2004-12-20

1996-12-18 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

2004-12-20 Publication of MA26414A1 publication Critical patent/MA26414A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA24433A 1995-12-23 1996-12-18 Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant. MA26414A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9526546.8A GB9526546D0 (en)	1995-12-23	1995-12-23	Compounds useful in therapy

Publications (1)

Publication Number	Publication Date
MA26414A1 true MA26414A1 (fr)	2004-12-20

Family

ID=10786091

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24433A MA26414A1 (fr)	1995-12-23	1996-12-18	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.

Country Status (34)

Country	Link
US (3)	US6103738A (fr)
EP (1)	EP0877734B1 (fr)
JP (1)	JP3070958B2 (fr)
KR (1)	KR19990076693A (fr)
AP (1)	AP715A (fr)
AR (1)	AR005166A1 (fr)
AT (1)	ATE194598T1 (fr)
AU (1)	AU708979B2 (fr)
BG (1)	BG102559A (fr)
BR (1)	BR9612263A (fr)
CA (1)	CA2236814C (fr)
CO (1)	CO4480106A1 (fr)
CZ (1)	CZ197698A3 (fr)
DE (1)	DE69609353T2 (fr)
DK (1)	DK0877734T3 (fr)
ES (1)	ES2151192T3 (fr)
GB (1)	GB9526546D0 (fr)
GR (1)	GR3034225T3 (fr)
HN (1)	HN1996000082A (fr)
HR (1)	HRP960616A2 (fr)
HU (1)	HUP9903560A3 (fr)
IS (1)	IS4731A (fr)
MA (1)	MA26414A1 (fr)
NO (1)	NO982913L (fr)
NZ (1)	NZ325248A (fr)
OA (1)	OA10703A (fr)
PL (1)	PL327610A1 (fr)
PT (1)	PT877734E (fr)
SK (1)	SK81698A3 (fr)
TN (1)	TNSN96161A1 (fr)
TR (1)	TR199801195T2 (fr)
WO (1)	WO1997023462A1 (fr)
YU (1)	YU68896A (fr)
ZA (1)	ZA9610784B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ325248A (en) *	1995-12-23	1999-09-29	Pfizer Res & Dev	Quinoline and quinazoline compounds useful in therapy
GB9700504D0 (en)	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
GB9708917D0 (en) *	1997-05-01	1997-06-25	Pfizer Ltd	Compounds useful in therapy
GB9711220D0 (en) *	1997-05-30	1997-07-23	Isis Innovation	Antiarrhythmic agents
GB9711650D0 (en) *	1997-06-05	1997-07-30	Pfizer Ltd	Compounds useful in therapy
DE60114852T2 (de)	2000-08-31	2006-07-27	F. Hoffmann-La Roche Ag	Chinazolin-derivate als alpha-1 adrenerge antagonisten
US6900220B2 (en)	2001-01-02	2005-05-31	Syntex (U.S.A.) Llc	Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
KR100554813B1 (ko) *	2001-01-02	2006-02-22	에프. 호프만-라 로슈 아게	알파 1에이/비 아드레날린성 수용체 길항제로서의퀴나졸론 유도체
US6734303B2 (en)	2001-05-18	2004-05-11	Pfizer Inc.	Process for the production of quinazolines
GB0206033D0 (en)	2002-03-14	2002-04-24	Pfizer Ltd	Compounds useful in therapy
EP1521747B1 (fr) *	2002-07-15	2018-09-05	Symphony Evolution, Inc.	Modulateurs de kinase de type recepteur et procedes d'utilisation
MXPA05002004A (es)	2002-09-26	2005-04-28	Pfizer	Derivados de pirazol.
CA2523431A1 (fr)	2003-04-23	2004-11-25	Glaxo Group Limited	Derives de piperazine et leur utilisation dans le traitement de maladies neurologiques et psychiatriques
US20050124562A1 (en) *	2003-09-23	2005-06-09	Joseph Guiles	Bis-quinazoline compounds for the treatment of bacterial infections
ES2925655T3 (es) *	2003-09-26	2022-10-19	Exelixis Inc	Moduladores c-Met y métodos de uso
US7495103B2 (en)	2004-06-24	2009-02-24	Vertex Pharmaceuticals Incorporated	Modulators of ATP-binding cassette transporters
CA2635581C (fr)	2005-12-28	2017-02-28	Vertex Pharmaceuticals Incorporated	Formes solides de n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoleine-3-carboxamide
US8496953B2 (en) *	2006-05-12	2013-07-30	W. L. Gore & Associates, Inc.	Immobilized biologically active entities having a high degree of biological activity following sterilization
US9114194B2 (en) *	2006-05-12	2015-08-25	W. L. Gore & Associates, Inc.	Immobilized biologically active entities having high biological activity following mechanical manipulation
US8986713B2 (en) *	2006-05-12	2015-03-24	W. L. Gore & Associates, Inc.	Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US20080279909A1 (en) *	2006-05-12	2008-11-13	Cleek Robert L	Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US8021677B2 (en)	2006-05-12	2011-09-20	Gore Enterprise Holdings, Inc.	Immobilized biologically active entities having a high degree of biological activity
NZ579480A (en)	2007-03-14	2012-03-30	Exelixis Patent Co Llc	2-Arylamino-quinazoline derivatives
US20100074949A1 (en)	2008-08-13	2010-03-25	William Rowe	Pharmaceutical composition and administration thereof
US12458635B2 (en)	2008-08-13	2025-11-04	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administrations thereof
AU2009315761A1 (en) *	2008-11-14	2010-05-20	F. Hoffmann-La Roche Ag	Quinazoline derivatives as NK3 receptor antagonists
KR20250123237A (ko)	2009-01-16	2025-08-14	엑셀리시스, 인코포레이티드	암의 치료를 위한 ｎ-（４-｛〔６，７-비스（메틸옥시）퀴놀린-4-일〕옥시｝페닐）-ｎ＇-（４-플루오로페닐）사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
SMT201700593T1 (it)	2009-03-20	2018-03-08	Vertex Pharma	Procedimento per preparare modulatori di regolatore di conduttanza transmembrana di fibrosi cistica
JP5770158B2 (ja) *	2009-03-23	2015-08-26	シプラ・リミテッド	ドキサゾシン及びその塩の製造方法
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
SG178592A1 (en)	2009-09-03	2012-04-27	Bristol Myers Squibb Co	Quinazolines as potassium ion channel inhibitors
US8591932B2 (en)	2009-09-17	2013-11-26	W. L. Gore & Associates, Inc.	Heparin entities and methods of use
KR101933237B1 (ko)	2011-03-11	2018-12-27	더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드	고정화된 생물학적 실체의 개선
US20140309184A1 (en) *	2011-09-21	2014-10-16	University Of South Alabama	Methods and compositions for the treatment of ovarian cancer
JP2015511583A (ja)	2012-02-27	2015-04-20	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	薬学的組成物およびその投与
NZ724691A (en)	2014-03-24	2018-02-23	Guangdong Zhongsheng Pharmaceutical Co Ltd	Quinoline derivatives as smo inhibitors
CA2963945C (fr)	2014-10-07	2023-01-10	Vertex Pharmaceuticals Incorporated	Co-cristaux de modulateurs du regulateur de conductance transmembranaire de la mucoviscidose
EP3448389B1 (fr)	2016-06-27	2021-09-29	Achillion Pharmaceuticals, Inc.	Composés de quinazoline et d'indole destinés au traitement de troubles médicaux
HUE069590T2 (hu) *	2019-01-18	2025-03-28	Astrazeneca Ab	PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4656174A (en) *	1982-07-24	1987-04-07	Pfizer Inc.	Quinoline therapeutic agents
GB8506174D0 (en) *	1985-03-09	1985-04-11	Pfizer Ltd	4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives
GB8814458D0 (en) *	1988-06-17	1988-07-20	Wyeth John & Brother Ltd	Heterocyclic compounds
NZ325248A (en) *	1995-12-23	1999-09-29	Pfizer Res & Dev	Quinoline and quinazoline compounds useful in therapy

1995
- 1995-12-23 NZ NZ325248A patent/NZ325248A/en unknown
- 1995-12-23 GB GBGB9526546.8A patent/GB9526546D0/en active Pending
1996
- 1996-12-05 AU AU13719/97A patent/AU708979B2/en not_active Ceased
- 1996-12-05 CA CA002236814A patent/CA2236814C/fr not_active Expired - Fee Related
- 1996-12-05 EP EP96943954A patent/EP0877734B1/fr not_active Expired - Lifetime
- 1996-12-05 TR TR1998/01195T patent/TR199801195T2/xx unknown
- 1996-12-05 AT AT96943954T patent/ATE194598T1/de not_active IP Right Cessation
- 1996-12-05 HU HU9903560A patent/HUP9903560A3/hu unknown
- 1996-12-05 DE DE69609353T patent/DE69609353T2/de not_active Expired - Fee Related
- 1996-12-05 SK SK816-98A patent/SK81698A3/sk unknown
- 1996-12-05 CZ CZ981976A patent/CZ197698A3/cs unknown
- 1996-12-05 BR BR9612263A patent/BR9612263A/pt not_active Application Discontinuation
- 1996-12-05 DK DK96943954T patent/DK0877734T3/da active
- 1996-12-05 US US09/091,370 patent/US6103738A/en not_active Expired - Fee Related
- 1996-12-05 KR KR1019980704806A patent/KR19990076693A/ko not_active Ceased
- 1996-12-05 JP JP9523272A patent/JP3070958B2/ja not_active Expired - Fee Related
- 1996-12-05 WO PCT/EP1996/005609 patent/WO1997023462A1/fr not_active Ceased
- 1996-12-05 PL PL96327610A patent/PL327610A1/xx unknown
- 1996-12-05 PT PT96943954T patent/PT877734E/pt unknown
- 1996-12-05 ES ES96943954T patent/ES2151192T3/es not_active Expired - Lifetime
- 1996-12-12 HN HN1996000082A patent/HN1996000082A/es unknown
- 1996-12-18 MA MA24433A patent/MA26414A1/fr unknown
- 1996-12-18 TN TNTNSN96161A patent/TNSN96161A1/fr unknown
- 1996-12-19 AP APAP/P/1996/000900A patent/AP715A/en active
- 1996-12-20 YU YU68896A patent/YU68896A/sh unknown
- 1996-12-20 CO CO96066994A patent/CO4480106A1/es unknown
- 1996-12-20 AR ARP960105804A patent/AR005166A1/es unknown
- 1996-12-20 ZA ZA9610784A patent/ZA9610784B/xx unknown
- 1996-12-23 HR HR9526546.8A patent/HRP960616A2/xx not_active Application Discontinuation
1998
- 1998-04-29 IS IS4731A patent/IS4731A/is unknown
- 1998-06-18 BG BG102559A patent/BG102559A/xx unknown
- 1998-06-22 NO NO982913A patent/NO982913L/no not_active Application Discontinuation
- 1998-06-23 OA OA9800092A patent/OA10703A/en unknown
2000
- 2000-08-17 GR GR20000401910T patent/GR3034225T3/el not_active IP Right Cessation
2001
- 2001-03-19 US US09/812,083 patent/US6642242B2/en not_active Expired - Fee Related
2003
- 2003-06-04 US US10/455,546 patent/US6750214B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO982913D0 (no)	1998-06-22
BR9612263A (pt)	1999-07-13
HUP9903560A2 (hu)	2000-05-28
US6642242B2 (en)	2003-11-04
AP9600900A0 (en)	1997-01-31
US6750214B2 (en)	2004-06-15
HRP960616A2 (en)	1998-06-30
WO1997023462A1 (fr)	1997-07-03
BG102559A (en)	1999-03-31
US20030220332A1 (en)	2003-11-27
JP3070958B2 (ja)	2000-07-31
US20020049322A1 (en)	2002-04-25
GR3034225T3 (en)	2000-12-29
OA10703A (en)	2002-11-28
CZ197698A3 (cs)	1999-03-17
IS4731A (is)	1998-04-29
SK81698A3 (en)	2000-04-10
ZA9610784B (en)	1998-06-22
YU68896A (sh)	1999-07-28
ATE194598T1 (de)	2000-07-15
TNSN96161A1 (fr)	2005-03-15
CO4480106A1 (es)	1997-07-09
AU708979B2 (en)	1999-08-19
EP0877734A1 (fr)	1998-11-18
DE69609353T2 (de)	2000-12-07
JPH11501668A (ja)	1999-02-09
AP715A (en)	1998-12-30
US6103738A (en)	2000-08-15
EP0877734B1 (fr)	2000-07-12
AR005166A1 (es)	1999-04-14
TR199801195T2 (xx)	1998-10-21
NZ325248A (en)	1999-09-29
GB9526546D0 (en)	1996-02-28
NO982913L (no)	1998-07-30
DE69609353D1 (de)	2000-08-17
PT877734E (pt)	2000-12-29
ES2151192T3 (es)	2000-12-16
KR19990076693A (ko)	1999-10-15
AU1371997A (en)	1997-07-17
DK0877734T3 (da)	2000-11-20
HN1996000082A (es)	1997-06-30
PL327610A1 (en)	1998-12-21
CA2236814C (fr)	2001-09-18
HUP9903560A3 (en)	2000-07-28
CA2236814A1 (fr)	1997-07-03

Publication	Publication Date	Title
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26428A1 (fr)	2004-12-20	Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
MA26439A1 (fr)	2004-12-20	Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26508A1 (fr)	2004-12-20	Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26614A1 (fr)	2004-12-20	Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23831A1 (fr)	1996-10-01	Derives de quinazoline, procede pour leur preparation et composition les contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2742148B1 (fr)	1999-10-22	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26680A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26438A1 (fr)	2004-12-20	Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26425A1 (fr)	2004-12-20	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr)	1997-04-18	Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .